Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Registry Evaluation of a Double Balloon Accessory Device

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03942965
Recruitment Status : Recruiting
First Posted : May 8, 2019
Last Update Posted : October 17, 2019
Information provided by (Responsible Party):
Lumendi, LLC

Brief Summary:
This study is collecting standard of care information pertaining to the use of the accessory device and patient outcomes when this double balloon accessory device is used during endoscopic procedures in the colon.

Condition or disease Intervention/treatment
Adenomatous Polyp of Colon Device: Double balloon accessory device

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 30 Days
Official Title: Multi-center Prospective Registry Study Utilizing a Double Balloon Accessory Device to Facilitate Endoscopic Polypectomy in Large Intestine.
Actual Study Start Date : January 22, 2019
Estimated Primary Completion Date : October 31, 2020
Estimated Study Completion Date : December 31, 2020

Intervention Details:
  • Device: Double balloon accessory device
    Double balloon accessory device is used during the endoscopic polypectomy procedure
    Other Name: DiLumen

Primary Outcome Measures :
  1. Ability to perform the procedure safely and effectively with the study device. [ Time Frame: Intraoperatively ]
    Investigator answers yes or no

Secondary Outcome Measures :
  1. Time to reach target lesion [ Time Frame: Intraoperatively ]
    Time measurement in hours and minutes

  2. Time to remove lesion after intervention begins [ Time Frame: Intraoperatively ]
    Time measurement in hours and minutes

  3. Total time using study device during case [ Time Frame: Intraoperatively ]
    Time measurement in hours and minutes

  4. Total case time [ Time Frame: Intraoperatively ]
    Time measurement in hours and minutes

  5. Total defect closure time [ Time Frame: Intraoperatively ]
    Time measurement in hours and minutes

  6. User feedback on device performance [ Time Frame: Intraoperatively ]
    Investigator rates the ease of use (easy, somewhat easy, somewhat difficult and difficult) of the device.

  7. Number of Study Subjects with Treatment Related Adverse Events [ Time Frame: Up to 30 days ]
    No moderate to severe mucosal injury, perforations or bleeding related to the use of the device.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Investigator's practice

Inclusion Criteria:

  1. Patients scheduled for endoscopic removal of suspected adenomatous benign polyps(s)
  2. Patients capable of giving informed consent in English
  3. No medical contraindication to endoscopic mucosal resection or endoscopic submucosal disection

Exclusion Criteria:

  1. No patients less than 18 years of age.
  2. Any contraindication to colonoscopy with due to subject's colon anatomy (i.e. stricture)
  3. History of open or laparoscopic colorectal surgery
  4. History of Inflammatory Bowel Disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03942965

Layout table for location contacts
Contact: April Goddard, PA-C 352-273-9483
Contact: Beth Carson, RN; MA 844-481-0822 ext 107

Layout table for location information
United States, Florida
University of Florida - Division of Gastroenterology, Hepatology and Nutrition Recruiting
Gainesville, Florida, United States, 32610
Contact: April Goddard, PA-C    352-273-9483   
United States, Pennsylvania
Geisinger Health System Recruiting
Danville, Pennsylvania, United States, 17822
Contact: David L Diehl, MD    800-275-6401   
Principal Investigator: David L Diehl, MD         
United States, Texas
Baylor College of Medicine Recruiting
Houston, Texas, United States, 77030
Contact: Chandra Kovvali    713-798-2308   
Principal Investigator: Mohamed Othman, MD         
Sponsors and Collaborators
Lumendi, LLC
Layout table for investigator information
Principal Investigator: Peter Draganov, MD University of Florida

Layout table for additonal information
Responsible Party: Lumendi, LLC Identifier: NCT03942965    
Other Study ID Numbers: DD_20
First Posted: May 8, 2019    Key Record Dates
Last Update Posted: October 17, 2019
Last Verified: May 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Product Manufactured in and Exported from the U.S.: Yes
Additional relevant MeSH terms:
Layout table for MeSH terms
Adenomatous Polyps
Colonic Polyps
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Intestinal Polyps
Pathological Conditions, Anatomical